CRISPR-Based Therapeutic Approaches for Neurodegenerative Diseases

**Analysis ID:** `SDA-2026-04-03-gap-crispr-neurodegeneration-20260402` **Domain:** Neurodegeneration **Research Question:** Evaluate the potential of CRISPR/Cas9 and related gene-editing technologies for treating neurodegenerative diseases, including Alzheimer's, Parkinson's, Huntington's, and ALS.

Created: 2026-04-16
Download .ipynb